Snap Laboratories L L C
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Snap Laboratories L L C stock price vs MGNI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MGNI's multiple
Needs Annual EPS.
Implied fair value · at Snap Laboratories L L C's multiple
Needs Snap Laboratories L L C P/E.
Engine logicSnap Laboratories L L Cvalued onMGNI’smultiple
Metric by metric
Where each company leads, and how wide the gap is.
Snapshot Sep 8, 2026, 4:00 PM ET
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Snap Laboratories L L C Latest annual filing · MGNI FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 82% equity / 18% debt · EV / Revenue 5.06x · EV / EBITDA 23.69x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SNAP LABORATORIES L L C · implied price per share
Reporting currency could not be verified.
MAGNITE, INC. · implied price per share
Bear
$13.83
Base
$16.28
Bull
$19.45
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Snap Laboratories L L C · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
—
0.83x
Net debt / EBITDA
Leverage against operating earnings
—
1.39x
Cash and equivalents
Liquid reserves on the balance sheet
—
$553.36M
Total debt
Interest-bearing obligations outstanding
—
$764.56M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.